Review on flavivirus vaccine development
| Autor: | Marie-Paule Kieny, V. Deubel, J. T. Roehrig, M. J. Cardosa, M. Guzman, Joachim Hombach, I. Kurane, A. Sabchareon, Alan D.T. Barrett |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Economic growth
medicine.medical_specialty General Veterinary General Immunology and Microbiology biology business.industry Public health Public Health Environmental and Occupational Health Japanese encephalitis medicine.disease biology.organism_classification Virology World health Dengue fever Vaccination Flavivirus Infectious Diseases Molecular Medicine Medicine Christian ministry Japanese encephalitis vaccine business medicine.drug |
| Zdroj: | Vaccine. 23:2689-2695 |
| ISSN: | 0264-410X |
| DOI: | 10.1016/j.vaccine.2004.11.040 |
| Popis: | In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26–27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect